Publication | Closed Access

Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficiency virus type 1

Medicinal ChemistryMedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyBicyclic Imidazo DerivativesSelective InhibitorsNew ClassPharmacotherapyAntiviral DrugHivPharmacologyAntiviral CompoundPharmaceutical ChemistryDrug Discovery